-
We are delighted to announce the availability of our new podcast titled Which medicines, taken by mouth or injected, work best to treat a skin condition called plaque psoriasis ? discussing the recently updated fourth edition review on systemic treatments for psoriasis, released in July 2023. To listen to the podcast, please click on this...
November 17 2023
-
Cochrane Skin is pleased to announce the publication of a new review, Treatments for alopecia areata.To find out more, consult the full review in the Cochrane Library.
October 25 2023
-
We are pleased to announce that a joint meeting of Cochrane Skin and the European Dermato-Epidemiology Network (EDEN) will be held in Paris, France from April 22 to 24, 2024. EDEN is a collaborative network of experts dedicated to advancing dermatological epidemiology research in Europe. ProgramApril 22 will be devoted to EDEN themes.April 23...
October 4 2023
-
Discover our new clinical vignette on strategies for using topical corticosteroids in patients with eczema on this link.The Cochrane Clinical Vignettes project has been launched by Cochrane France as part of its mission to promote evidence-based decision-making and practice. This collaborative project with...
September 15 2023
-
Cochrane Skin is pleased to announce the publication of the updated version of the living review Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis. This new version included 179 randomized clinical trials with 62,339 participants with moderate to severe psoriasis.Key messagesThe biologics...
September 7 2023
-
Cochrane Skin is pleased to announce the publication of a new review, Interventions for bullous pemphigoid. This updated review included 14 randomized clinical trials with 442 participants diagnosed with bullous pemphigoid.Key messagesClobetasol propionate cream applied all over the skin is probably as effective as oral prednisone in treating...
September 7 2023
-
The 2022 Cochrane Review Group Impact Factor for the Cochrane Skin Group increased to 9.258. This therefore means that a review published by the Skin Group Skin Group in 2020 and 2021 was cited, on average, 9.2 times in 2022. This represents an increase on the 2021 Impact Factor, which was 7.400. Thank you to all who have contributed!...
August 31 2023
-
As part of its mission to promote evidence-based decision-making and practice, Cochrane France has launched the Cochrane Clinical Vignettes project. This collaborative project with Cochrane Skin, Cochrane Lung Cancer and Cochrane Training aims to produce several clinical vignettes a year covering different...
June 13 2023
-
Druing the Cochrane Colloquium in London from September 3-6, 2023, we had the opportunity to hold our Cochrane Skin Group meeting, which proved to be rich in interesting sessions and exchanges. It was a real pleasure to bring our team together.We were also fortunate to have two interesting communications from the Taiwanese team, which brought new...
May 30 2023
-
Cochrane Skin moved to a new home in France near Paris in April 2023. We are very grateful to the French Dermatology Society, our main funder, for its support. Laurence Le Cleach assumes the role of Co-ordinating Editor together with Bob Boyle in London and Ching-Chi Chi in Taiwan as deputy Editors.
May 30 2023
We are delighted to announce the availability of our new podcast titled Which medicines, taken by mouth or injected, work best to treat a skin condition called plaque psoriasis ? discussing the recently updated fourth edition review on systemic treatments for psoriasis, released in July 2023. To listen to the podcast, please click on this...November 17 2023
Cochrane Skin is pleased to announce the publication of a new review, Treatments for alopecia areata.To find out more, consult the full review in the Cochrane Library.October 25 2023
We are pleased to announce that a joint meeting of Cochrane Skin and the European Dermato-Epidemiology Network (EDEN) will be held in Paris, France from April 22 to 24, 2024. EDEN is a collaborative network of experts dedicated to advancing dermatological epidemiology research in Europe. ProgramApril 22 will be devoted to EDEN themes.April 23...October 4 2023
Discover our new clinical vignette on strategies for using topical corticosteroids in patients with eczema on this link.The Cochrane Clinical Vignettes project has been launched by Cochrane France as part of its mission to promote evidence-based decision-making and practice. This collaborative project with...September 15 2023
Cochrane Skin is pleased to announce the publication of the updated version of the living review Systemic pharmacological treatments for chronic plaque psoriasis: a network meta‐analysis. This new version included 179 randomized clinical trials with 62,339 participants with moderate to severe psoriasis.Key messagesThe biologics...September 7 2023
Cochrane Skin is pleased to announce the publication of a new review, Interventions for bullous pemphigoid. This updated review included 14 randomized clinical trials with 442 participants diagnosed with bullous pemphigoid.Key messagesClobetasol propionate cream applied all over the skin is probably as effective as oral prednisone in treating...September 7 2023
The 2022 Cochrane Review Group Impact Factor for the Cochrane Skin Group increased to 9.258. This therefore means that a review published by the Skin Group Skin Group in 2020 and 2021 was cited, on average, 9.2 times in 2022. This represents an increase on the 2021 Impact Factor, which was 7.400. Thank you to all who have contributed!...August 31 2023
As part of its mission to promote evidence-based decision-making and practice, Cochrane France has launched the Cochrane Clinical Vignettes project. This collaborative project with Cochrane Skin, Cochrane Lung Cancer and Cochrane Training aims to produce several clinical vignettes a year covering different...June 13 2023
Cochrane Skin moved to a new home in France near Paris in April 2023. We are very grateful to the French Dermatology Society, our main funder, for its support. Laurence Le Cleach assumes the role of Co-ordinating Editor together with Bob Boyle in London and Ching-Chi Chi in Taiwan as deputy Editors.May 30 2023